Cencora Inc

Research Cencora Inc (COR) on Bullrun: valuation model: 20.8% overvalued, market cap USD 61.80B, P/E 24.1, dividend yield 0.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

Bullrun's latest valuation model marks Cencora Inc as 20.8% overvalued; latest market cap is USD 61.80B; P/E is 24.1; dividend yield is 0.7%.

Peer valuation comparison

Latest P/E is 24.08x versus a Healthcare sector median of 24.64x (2.3% below).

Latest dividend yield is 0.74% versus a Healthcare sector median of 1.83% (59.5% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 321.33BUSD 1.55BUSD 3.21B3.6%7.96USD 4.36BUSD 7.66BUSD 1.51B
FY2024USD 293.96BUSD 1.51BUSD 3.00B3.4%7.53USD 3.13BUSD 4.39BUSD 645.94M
FY2023USD 262.17BUSD 1.75BUSD 3.45B3.4%8.53USD 2.59BUSD 4.79BUSD 522.00M
FY2022USD 238.59BUSD 1.70BUSD 2.21B3.5%8.04USD 3.39BUSD 5.70B-USD 211.56M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-09USD 61.80B24.10.7%2.4
20252025-12-31USD 65.70B40.60.7%2.25
20242024-12-31USD 43.55B32.00.9%2.08
20232023-12-29USD 41.02B24.11.0%1.98
20222022-12-30USD 33.49B20.61.1%1.87
20212021-12-31USD 27.78B17.31.3%1.78

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.4 USD, yield 0.7%.

YearDividends/share
FY20252.2 USD
FY20242.04 USD
FY20231.94 USD
FY20221.84 USD

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers;

ETFs that hold Cencora Inc

Cencora Inc is one of the ten largest holdings of 11 ETFs that investors in Europe can buy. The 8 most traded of them:

ETFWeightTER
iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc)1.27%0.30%
JPM Global Equity Premium Income Active UCITS ETF - USD (dist)1.14%0.35%
Xtrackers MSCI World Minimum Volatility UCITS ETF 1C1.29%0.25%
iShares Edge MSCI World Minimum Volatility Advanced UCITS ETF USD (Acc)1.26%0.30%
JPM Global Equity Premium Income Active UCITS ETF EUR Inc1.14%0.35%
iShares Edge MSCI World Minimum Volatility UCITS ETF EUR Hedged (Acc)1.27%0.35%
Amundi S&P 400 US Mid Cap UCITS ETF Accumulation4.30%0.20%
JPM Global Equity Premium Income Active UCITS ETF - USD (acc)1.14%0.35%

Compare every fund on the same index:

MSCI World Minimum Volatility ETFs

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

Owens & Minor Inc (ACH) Cardinal Health Inc (CAH) Henry Schein Inc (HSIC) Mckesson Corporation (MCK) Synergy CHC Corp (SNYR) Wellgistics Health Inc (WGRX) Agilent Technologies Inc (A) Aardvark Therapeutics Inc (AARD) Abbvie Inc (ABBV) Abeona Therapeutics Inc (ABEO) Acumen Pharmaceuticals Inc (ABOS) Absci Corp (ABSI)

Frequently asked questions

Is Cencora Inc overvalued or undervalued?

Bullrun's valuation model currently marks Cencora Inc as 20.8% overvalued.

What is Cencora Inc's market cap?

Cencora Inc's market capitalization is USD 61.80B.

What is Cencora Inc's P/E ratio?

Cencora Inc's price-to-earnings (P/E) ratio is 24.1.

Does Cencora Inc pay a dividend?

Cencora Inc has a dividend yield of 0.7%.

What does Cencora Inc do?

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S.